dc.contributor | Vall d'Hebron Barcelona Hospital Campus |
dc.contributor.author | Mirallas Viñas, Oriol |
dc.contributor.author | Pardo Aranda, Nuria |
dc.contributor.author | Aubanell, Anton |
dc.contributor.author | Salcedo Allende, Maria Teresa |
dc.contributor.author | Callejo Perez, Ana |
dc.contributor.author | Iranzo Gómez, Patricia |
dc.contributor.author | Tabernero Caturla, Josep |
dc.contributor.author | Felip Font, Enriqueta |
dc.contributor.author | Bosch Schips, Marc |
dc.date.accessioned | 2022-09-05T11:41:30Z |
dc.date.available | 2022-09-05T11:41:30Z |
dc.date.issued | 2022-03 |
dc.identifier.citation | Mirallas O, Bosch-Schips M, Pardo N, Aubanell A, Salcedo-Allende MT, Callejo A, et al. Hepatic Rupture as the Initial Presentation of an EGFR-Mutated Lung Adenocarcinoma: A Case Report. Front Oncol. 2022 Mar;12:837630. |
dc.identifier.issn | 2234-943X |
dc.identifier.uri | https://hdl.handle.net/11351/8026 |
dc.description | Ruptura hepática metastásica; Carcinoma de pulmón de células no pequeñas; Inhibidor de la tirosina quinasa |
dc.language.iso | eng |
dc.publisher | Frontiers Media |
dc.relation.ispartofseries | Frontiers in Oncology;12 |
dc.rights | Attribution 4.0 International |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ |
dc.source | Scientia |
dc.subject | Adenocarcinoma - Tractament |
dc.subject | Pulmons - Càncer - Tractament |
dc.subject | Proteïnes quinases - Inhibidors |
dc.subject.mesh | Adenocarcinoma of Lung |
dc.subject.mesh | /therapy |
dc.subject.mesh | Protein Kinase Inhibitors |
dc.title | Hepatic Rupture as the Initial Presentation of an EGFR-Mutated Lung Adenocarcinoma: A Case Report |
dc.type | info:eu-repo/semantics/article |
dc.identifier.doi | 10.3389/fonc.2022.837630 |
dc.subject.decs | adenocarcinoma de pulmón |
dc.subject.decs | /terapia |
dc.subject.decs | inhibidores de proteínas cinasas |
dc.relation.publishversion | https://doi.org/10.3389/fonc.2022.837630 |
dc.type.version | info:eu-repo/semantics/publishedVersion |
dc.audience | Professionals |
dc.contributor.organismes | Institut Català de la Salut |
dc.contributor.authoraffiliation | [Mirallas O, Pardo N, Callejo A, Iranzo P, Tabernero J, Felip E] Servei d’Oncologia Mèdica, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. [Bosch-Schips M] Servei d’Hematologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. [Aubanell A] Servei de Radiologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. [Salcedo-Allende MT] Servei de Patologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain |
dc.identifier.pmid | 35433405 |
dc.identifier.wos | 000788209600001 |
dc.rights.accessrights | info:eu-repo/semantics/openAccess |